from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3278c/-

LFCtreatmentdescriptionclass of inhibitor

0.558

Amikacinug/mL Amikacintranslation

-0.056

Cap5-10ug/mL Capreomycintranslation

-0.461

Rox10-50 ug/mL Roxithromycintranslation

-0.364

SM2-5 ug/mL Streptomycintranslation

0.861

Tet5-10 ug/mL Tetracyclinetranslation

1.947

Rif0.2-5ug/mL Rifampicintranscription

0.341

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.683

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.786

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.385

CPZ10-50 ug/mL Chlorpromazinerespiration

0.583

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.307

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.870

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.452

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.892

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.203

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.216

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.881

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.794

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.569

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.552

KCN5-20 ug/mL Potassium cyaniderespiration

-0.685

NaN30.2-2 mM Sodium aziderespiration

-0.582

Nigericin50 uM Nigericinrespiration

1.147

TRC10-150 ug/mL Triclosanrespiration

2.482

TRZ10-25 ug/mL Thioridazinerespiration

-0.709

Valinomycin0.5-10 uM Valinomycinrespiration

-0.611

ZnSO42 mM ZnSO4respiration

0.740

menadione6-10 ug/mL Menadionerespiration

0.046

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.383

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.002

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.326

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.035

NRP_1Non-replicating persistence stage 1dosRassociated

-0.695

Amp0.2mg/mL AmpicillincellWall

0.291

Cephalexin20-100 ug/mL CephalexincellWall

-0.154

Cerulenin0.32-5 ug/mL CerulenincellWall

0.744

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.451

EMB10-20 ug/mL EthambutolcellWall

-0.205

Eta12-40 ug/mL EthionamidecellWall

-0.447

INH0.2-0.4 ug/mL IsoniazidcellWall

0.019

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.140

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.317

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.220

BZA0.12 mg/mL BenzamidearomaticAmides

0.048

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.746

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.025

H2O24 mM hydrogen peroxideDNAdamaging

-0.433

Levo10 ug/mL LevofloxacinDNAdamaging

-0.717

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.092

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.133

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.402

UVUV-irradiationDNAdamaging

1.153

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.705

Antimycin12.5-50 ug/mL Antimycin A?

0.133

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.387

PA_110-50 ug/mL Antitubercular compound PA-1?

0.301

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.068

PA8240.2-2 ug/mL PA-824?

0.069

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.223

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.198

Verapamil50 uM Verapamil?

0.353

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.389

methoxatin10-20 ug/mL Methoxatin?